by The United States viscosupplementation market comprises injectable hyaluronic acid-based drugs that function as joint lubricants and supplements for the treatment of osteoarthritis associated pain. Viscosupplementation involves injection of hyaluronic acid into the joint cavity to supplement endogenous hyaluronic acid and reduce pain and inflammation. Osteoarthritis is a major cause of musculoskeletal disability in the United States affecting over 30 million adults. The pain and impaired movement resulting from osteoarthritis cause significant health and economic burden. Viscosupplementation has emerged as an effective treatment for pain management in knee and hip osteoarthritis.
The Global United States viscosupplementation Market is estimated to be valued at US$ 1.54 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the United States viscosupplementation are Anika Therapeutics Inc., Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, and Zimmer Biomet. These leading players are focused on new product launches and strategic collaborations to strengthen their market position.
The growing prevalence of osteoarthritis fueled by rising obesity, musculoskeletal disorders and aging population is driving the demand for viscosupplementation in the United States. According to CDC, over 30 million adults suffer from osteoarthritis in the U.S. The market is expected to witness increased adoption with rising awareness about viscosupplementation as a minimally invasive treatment option.
The market is witnessing expansion into new regions within the U.S. led by increasing availability through partnerships with regional medical centers and orthopedic clinics. Market players are promoting viscosupplementation for treatment of arthritis in shoulder, ankle and other small joints in addition to knee and hip.
Market Key Trends
The market is witnessing the trend of shorter treatment cycles with double dose injections. Earlier three injections were given once a week but now trials are occurring with two injections given within a few days to provide long term relief. Additionally, combination therapies with hyaluronic acid and platelet rich plasma injections are gaining interest for enhanced therapeutic efficacy in osteoarthritis. Players are increasingly focusing on concentrated triple cross linked hyaluronic acid formulations for prolonged duration of pain relief.
Porter’s Analysis
Threat of new entrants: New companies must invest significant capital to establish infrastructure and distribution channels in this market.
Bargaining power of buyers: Healthcare providers and patients have significant influence over choice of viscosupplementation products due to clinical efficacy and safety concerns.
Bargaining power of suppliers: Key raw material suppliers exert influence through supply agreements and contract terms.
Threat of new substitutes: Alternative joint pain treatment options like stem cell therapy and drugs pose threat.
Competitive rivalry: Companies compete on product differentiation, branding and marketing.
Geographical Regions For Viscosity Market Value Concentration
North America region accounts for the largest share of the United States of America Viscosupplementation market value, estimated to be around 65% in 2024. Presence of major players, higher adoption rates and developed healthcare infrastructure support market growth in this region.
Fastest Growing Region For Viscosity Market
Asia Pacific region is poised to witness the highest CAGR of over 10% during the forecast period. Increasing geriatric population, growing medical tourism and rapidly developing healthcare facilities are driving the viscosupplementation market in emerging countries of China and India.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
What Are The Key Data Covered In This United States of America Viscosupplementation Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the United States of America Viscosupplementation ‘s growth between 2024 and 2031.
:- Accurate calculation of the size of the United States of America Viscosupplementation and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- United States of America Viscosupplementation Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of United States of America Viscosupplementation vendors
FAQ’s
Q.1 What are the main factors influencing the United States of America Viscosupplementation ?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top United States of America Viscosupplementation companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the United States of America Viscosupplementation ’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
What Are The Key Data Covered In This United States of America Viscosupplementation Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the United States of America Viscosupplementation ‘s growth between 2024 and 2031.
:- Accurate calculation of the size of the United States of America Viscosupplementation and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- United States of America Viscosupplementation Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of United States of America Viscosupplementation vendors
FAQ’s
Q.1 What are the main factors influencing the United States of America Viscosupplementation ?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top United States of America Viscosupplementation companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the United States of America Viscosupplementation ’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile
